Zydus Lifesciences Limited has informed the Exchange regarding a press release dated January 12, 2023, titled "Zydus receivesfinal approval and 180 days shared exclusivity from the USFDA for Brexpiprazole Tablets".
Press Release Jan 12 2023
Filed with NSE ·
6ix hasn’t read this filing yet.
Zydus Lifesciences Limited on 6ix
Earlier from Zydus Lifesciences
- Press Release Jan 10 2023
- Press Release Jan 06 2023
- Press Release Dec 30 2022
- Loss of Share Certificates
- Press Release Dec 22 2022
Later from Zydus Lifesciences
- Zydus Lifesciences Limited Press Release Jan 16 2023
- Press Release Jan 27 2023
- Press Release Feb 15 2023
- Zydus Lifesciences Limited Press Release Feb 17 2023
- Zydus Lifesciences Limited Press Release Feb 20 2023
Follow Zydus Lifesciences into a list and get an email when it puts out news.
Follow Zydus Lifesciences